Magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment for uterine fibroids
2010

Magnetic Resonance-Guided Focused Ultrasound Surgery for Uterine Fibroids

Sample size: 54 publication 10 minutes Evidence: moderate

Author Information

Author(s): Abdullah BJJ MBBS, FRCR, Subramaniam RV, Omar SS, Wragg P, Ramli N FRCR, Wui AL, Lee CC, Yusof Y

Primary Institution: Department of Biomedical Imaging, University of Malaya

Hypothesis

MRgFUS is an effective non-invasive treatment for symptomatic uterine fibroids.

Conclusion

MRgFUS is a safe and effective treatment for symptomatic uterine fibroids, offering a non-invasive alternative to traditional surgical methods.

Supporting Evidence

  • MRgFUS can be offered to a majority of patients suffering from symptomatic uterine fibroids.
  • Studies show that MRgFUS significantly improves clinical symptoms in 70% to 80% of women with uterine myomas.
  • MRgFUS requires no general anaesthesia and can be performed as an outpatient procedure.
  • Safety data show few serious adverse events related to MRgFUS.
  • Live births occurred in 41% of pregnancies after MRgFUS treatment.

Takeaway

Doctors can use a special ultrasound treatment to help women with painful growths in their uterus without needing to do major surgery.

Methodology

The study describes the MRgFUS procedure, including patient selection, treatment planning, and monitoring outcomes.

Potential Biases

Potential bias in patient selection criteria and reporting of outcomes.

Limitations

The study does not provide long-term evidence for the clinical benefit of treating adenomyosis with MRgFUS.

Participant Demographics

Women of childbearing age with symptomatic uterine fibroids.

Statistical Information

P-Value

0.01

Confidence Interval

Not provided

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.2349/biij.6.2.e15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication